BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24362313)

  • 21. Detection of SPG20 gene promoter-methylated DNA, as a novel epigenetic biomarker, in plasma for colorectal cancer diagnosis using the MethyLight method.
    Rezvani N; Alibakhshi R; Vaisi-Raygani A; Bashiri H; Saidijam M
    Oncol Lett; 2017 May; 13(5):3277-3284. PubMed ID: 28521434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
    Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
    Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
    Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
    BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
    Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
    J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypermethylated MAL gene - a silent marker of early colon tumorigenesis.
    Lind GE; Ahlquist T; Kolberg M; Berg M; Eknaes M; Alonso MA; Kallioniemi A; Meling GI; Skotheim RI; Rognum TO; Thiis-Evensen E; Lothe RA
    J Transl Med; 2008 Mar; 6():13. PubMed ID: 18346269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas.
    Ying J; Li H; Murray P; Gao Z; Chen YW; Wang Y; Lee KY; Chan AT; Ambinder RF; Srivastava G; Tao Q
    Epigenetics; 2007; 2(1):15-21. PubMed ID: 17965626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between lymphoma prognosis and aberrant methylation of ID4 and ZO-1 in bone marrow and paraffin-embedded lymphoma tissues of treatment-naive patients.
    Cen J; Shen J; Wang X; Kang H; Wang L; Sun L; Li Y; Yu L
    Oncol Rep; 2013 Jul; 30(1):455-61. PubMed ID: 23670122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
    Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
    Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retinoic acid-induced 2 (RAI2) is a novel tumor suppressor, and promoter region methylation of RAI2 is a poor prognostic marker in colorectal cancer.
    Yan W; Wu K; Herman JG; Xu X; Yang Y; Dai G; Guo M
    Clin Epigenetics; 2018; 10():69. PubMed ID: 29796120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of exon methylation biomarkers for colorectal cancer via LC-MS/MS strategy.
    Huang Q; Yang Q; Mo M; Ye X; Zhang J; Zhang L; Chen B; Li J; Cai C
    J Mass Spectrom; 2017 Dec; 52(12):860-866. PubMed ID: 28940471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors.
    Poeta ML; Massi E; Parrella P; Pellegrini P; De Robertis M; Copetti M; Rabitti C; Perrone G; Muda AO; Molinari F; Zanellato E; Crippa S; Caputo D; Caricato M; Frattini M; Coppola R; Fazio VM
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1133-43. PubMed ID: 22927297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-scale discovery of DNA-methylation biomarkers for blood-based detection of colorectal cancer.
    Lange CP; Campan M; Hinoue T; Schmitz RF; van der Meulen-de Jong AE; Slingerland H; Kok PJ; van Dijk CM; Weisenberger DJ; Shen H; Tollenaar RA; Laird PW
    PLoS One; 2012; 7(11):e50266. PubMed ID: 23209692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation of
    Zheng R; Gao D; He T; Zhang M; Zhang X; Linghu E; Wei L; Guo M
    Clin Epigenetics; 2017; 9():50. PubMed ID: 28491151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
    Melson J; Li Y; Cassinotti E; Melnikov A; Boni L; Ai J; Greenspan M; Mobarhan S; Levenson V; Deng Y
    Int J Cancer; 2014 Jun; 134(11):2656-62. PubMed ID: 24288256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant hypermethylation of OGDHL gene promoter in sporadic colorectal cancer.
    Khalaj-Kondori M; Hosseinnejad M; Hosseinzadeh A; Behroz Sharif S; Hashemzadeh S
    Curr Probl Cancer; 2020 Feb; 44(1):100471. PubMed ID: 30904169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients.
    Guo Q; Song Y; Zhang H; Wu X; Xia P; Dang C
    Med Oncol; 2013 Dec; 30(4):695. PubMed ID: 23963856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IGFBP3 gene promoter methylation analysis and its association with clinicopathological characteristics of colorectal carcinoma.
    Kumar A; Singh P; Pandey A; Gosipatala SB
    Mol Biol Rep; 2020 Sep; 47(9):6919-6927. PubMed ID: 32929656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Promoter Methylation Status of Two Novel Human Genes, UBE2Q1 and UBE2Q2, in Colorectal Cancer: a New Finding in Iranian Patients.
    Mokarram P; Shakiba-Jam F; Kavousipour S; Sarabi MM; Seghatoleslam A
    Asian Pac J Cancer Prev; 2015; 16(18):8247-52. PubMed ID: 26745068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.